A preliminary report on the safety and pharmacokinetics of ibogaine

Abstract

Antipsychotic plasma level or dose/clinical response relationships can be viewed as parallel issues, in that they both may define a threshold for response as well as an upper end to a possible therapeutic window. We have conducted a two-phase targeted haloperidol plasma level study …